Ascentage Pharma Group International (HKG:6855)
40.58
+0.50 (1.25%)
May 28, 2026, 9:30 AM HKT
Ascentage Pharma Group International Employees
Ascentage Pharma Group International had 605 employees as of June 30, 2025. The number of employees increased by 38 or 6.70% since the number was reported on December 31, 2024.
Employees
605
Change
38
Growth
6.70%
Revenue / Employee
832.97K HKD
Profits / Employee
-1.80M HKD
Market Cap
14.75B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2025 | 605 | 38 | 6.70% |
| Dec 31, 2024 | 567 | -16 | -2.74% |
| Dec 31, 2023 | 583 | 3 | 0.52% |
| Dec 31, 2022 | 580 | -33 | -5.38% |
| Dec 31, 2021 | 613 | 180 | 41.57% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Zai Lab | 1,784 |
| Keymed Biosciences | 1,625 |
| Everest Medicines | 812 |
| CARsgen Therapeutics Holdings | 355 |
| Duality Biotherapeutics | 231 |
| HBM Holdings | 210 |
| Ascletis Pharma | 202 |
| CStone Pharmaceuticals | 136 |
Ascentage Pharma Group International News
- 6 days ago - Ascentage Pharma Releases Latest Clinical Data from Multiple Trials at ASCO 2026 - GlobeNewsWire
- 14 days ago - Ascentage Pharma to Present 17 Clinical Advances at 2026 European Hematology Association Congress - GlobeNewsWire
- 15 days ago - Ascentage Pharma to Participate in Three Upcoming Investor Conferences - GlobeNewsWire
- 4 weeks ago - Ascentage Pharma initiated with a Buy at Deutsche Bank - TheFly
- 5 weeks ago - Ascentage Pharma to Present Data from Multiple Trials, Including Three Rapid Oral Presentations, at ASCO 2026 - GlobeNewsWire
- 5 weeks ago - Ascentage Pharma to Present Four Promising Preclinical Studies Demonstrating the Potential of Combination Therapies at American Association for Cancer Research (AACR) 2026 Annual Meeting - GlobeNewsWire
- 2 months ago - Full Year 2025 Ascentage Pharma Group International Earnings Presentation Transcript - GuruFocus
- 2 months ago - Ascentage Pharma Reports Full Year 2025 Unaudited Financial Results and Provides Business Updates - GlobeNewsWire